CS logo
small CS logo
Charlotte Eye, Ear, Nose and Throat Assoc., PA

Charlotte, North Carolina, United States
Ophthalmologist in Statesville, North Carolina
646 Hartness Rd, Statesville, NC 28677

About Charlotte Eye, Ear, Nose and Throat Assoc., PA


"Charlotte Eye Ear Nose & Throat Associates, P.A. is the premier source for eye, ear, nose, and throat care throughout the Carolinas. Our award-winning medical staff is well trained in treating both common and complicated medical conditions. With more than 100 providers in nearly 20 locations, finding treatment for your eye, ear, nose, and throat needs has never been easier. Click on the selections in the menu bar to learn more about all the treatment CEENTA offers. Virtual visits can now be requested by calling 704.295.3003. Most ENT conditions and select eye conditions qualify for virtual visits."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Jaeb Center for Health Research
20
Hoffmann-La Roche
15
Genentech, Inc.
6
Aerie Pharmaceuticals
5
Allergan
4
Apellis Pharmaceuticals, Inc.
3
Ionis Pharmaceuticals, Inc.
3
National Eye Institute (NEI)
3
Otonomy, Inc.
3
Chakshu Research, Inc.
2
Eyetech Pharmaceuticals
2
Total Rows: 43

Clinical Trials at Charlotte Eye, Ear, Nose and Throat Assoc., PA


During the past decade, Charlotte Eye, Ear, Nose and Throat Assoc., PA conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 43 clinical trials were completed, i.e. on average, 93.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 25 clinical trials were completed. i.e. 250% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years99555512125588222244223377121288Started TrialsCompleted Trails2015201620172018201920202021051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
Completed
A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes
Completed
60
The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes
Completed
Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
2004-05-01
Completed
90
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
2004-07-01
2006-01-01
Completed
685
A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration
2005-06-01
Terminated
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
1998-11-01
2003-03-01
Completed
750
A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
2006-04-01
2006-11-01
Terminated
262

Rows per page:

1–100 of 104

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" #1 sponsor was "Jaeb Center for Health Research" with 20 trials, followed by "Hoffmann-La Roche" with 15 trials sponsored, "Genentech, Inc." with 6 trials sponsored, "Aerie Pharmaceuticals" with 5 trials sponsored and "Allergan" with 5 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" #1 collaborator was "National Eye Institute (NEI)" with 21 trials as a collaborator, "Genentech, Inc." with 7 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Regeneron Pharmaceuticals" with 5 trials as a collaborator and "Allergan" with 4 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 21 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJaeb Center for HealthResearch: 20Jaeb Center for HealthResearch: 20Hoffmann-La Roche: 15Hoffmann-La Roche: 15Genentech, Inc.: 6Genentech, Inc.: 6Aerie Pharmaceuticals: 5Aerie Pharmaceuticals: 5Allergan: 4Allergan: 4Apellis Pharmaceuticals, Inc.: 3Apellis Pharmaceuticals, Inc.: 3Ionis Pharmaceuticals, Inc.: 3Ionis Pharmaceuticals, Inc.: 3National Eye Institute (NEI): 3National Eye Institute (NEI): 3Otonomy, Inc.: 3Otonomy, Inc.: 3Chakshu Research, Inc.: 2Chakshu Research, Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsNational Eye Institute (NEI): 21National Eye Institute (NEI): 21Genentech, Inc.: 7Genentech, Inc.: 7National Institutes ofHealth (NIH): 6National Institutes ofHealth (NIH): 6Regeneron Pharmaceuticals: 5Regeneron Pharmaceuticals: 5Allergan: 4Allergan: 4Bayer: 2Bayer: 2Juvenile DiabetesResearch Foundation: 2Juvenile DiabetesResearch Foundation: 2Pfizer: 2Pfizer: 2Kowa Company, Ltd.: 1Kowa Company, Ltd.: 1Milton S. HersheyMedical Center: 1Milton S. HersheyMedical Center: 1

Clinical Trials Conditions at Charlotte Eye, Ear, Nose and Throat Assoc., PA


According to Clinical.Site data, the most researched conditions in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" are "Diabetic Macular Edema" (19 trials), "Geographic Atrophy" (12 trials), "Diabetic Retinopathy" (11 trials), "Ocular Hypertension" (8 trials) and "Macular Degeneration" (7 trials). Many other conditions were trialed in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" in a lesser frequency.

Clinical Trials Intervention Types at Charlotte Eye, Ear, Nose and Throat Assoc., PA


Most popular intervention types in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" are "Drug" (86 trials), "Other" (22 trials), "Procedure" (10 trials), "Device" (8 trials) and "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Sham Procedure" (10 trials), "Ranibizumab" (8 trials), "Faricimab" (6 trials) and "Aflibercept" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Charlotte Eye, Ear, Nose and Throat Assoc., PA


The vast majority of trials in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" are 104 trials for "All" genders.

Clinical Trials Status at Charlotte Eye, Ear, Nose and Throat Assoc., PA


Currently, there are NaN active trials in "Charlotte Eye, Ear, Nose and Throat Assoc., PA". undefined are not yet recruiting, 1 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 78 completed trials in Charlotte Eye, Ear, Nose and Throat Assoc., PA, undefined suspended trials, and 13 terminated clinical trials to date.
Out of the total trials that were conducted in Charlotte Eye, Ear, Nose and Throat Assoc., PA, 7 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 46Phase 3: 46Phase 2: 40Phase 2: 40Not Applicable: 7Not Applicable: 7Phase 1: 7Phase 1: 7Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 78Completed: 78Terminated: 13Terminated: 13Active, not recruiting: 8Active, not recruiting: 8Unknown status: 3Unknown status: 3Recruiting: 1Recruiting: 1Withdrawn: 1Withdrawn: 1